Tylosin (as tartrate) 150 mg, Gentamicin sulphate 60 mg, Dexamethasone sodium phosphate 0.265 mg, Chlorphenamine maleate 7.5 mg, excipients q.s.ad. 1 mL
Tylo-Combisone®
Injectable Solution
Antibiotic, anti-inflammatory and antihistamine combination
Formulation
Indications
For the treatment and prevention of infections caused by tylosin and/or gentamicin sensitive microoganisms. Respiratory infections (pneumonia, bronchopmeumonia), mastitis, footrot, erysipelas, endometritis, arthritis, gastrointestinal infections in general. The dexamethasone provides an antiinflammatory, antistress and glucogeogenic effect. The chorphenamine, as an antihistaminic, reduces allergic signs.
Dosage and Administration
Large animals: 1 mL/15 kg of b.w. every 24 hours for 3 consecutive days by deep intramuscular route.
Commercial Presentation
Bottle x 20 mL , Bottle x 50 mL , Bottle x 100 mL , Bottle x 250 mL ,
registro SAGARPA
México Registro SAGARPA Q-0616-005
MORE VISITED PRODUCTS
